Skip navigation
BelSU DSpace logo

Please use this identifier to cite or link to this item: http://dspace.bsuedu.ru/handle/123456789/66372
Title: Semaglutide reduces hypothalamic glial cell damage in a streptozocin-induced model of Alzheimer's disease
Authors: Voronkov, D. N.
Stavrovskaya, A. V.
Pavlova, A. K.
Potapov, I. A.
Olshansky, A. S.
Keywords: medicine
pharmacology
astrocytes
ependymal cells
Alzheimer's disease
streptozotocin
semaglutide
Issue Date: 2025
Citation: Semaglutide reduces hypothalamic glial cell damage in a streptozocin-induced model of Alzheimer's disease / D.N. Voronkov, A.V. Stavrovskaya, A.K. Pavlova [et al.] // Research Results in Pharmacology. - 2025. - Vol.11, №4.-P. 66-77. - Doi: 10.18413/rrpharmacology.11.804. - Refer.: p. 75-77.
Abstract: Reactive changes in glial cells, as well as their dysfunction, particularly cerebrospinal fluid dynamics disturbances, are associated with multiple neurodegenerative diseases and Alzheimer’s disease (AD). Intraventricular administration of streptozotocin (STZ) is considered a model of sporadic AD, though data on hypothalamic glial cell changes, ependymal glia, and tanycytes in this model remain limited
URI: http://dspace.bsuedu.ru/handle/123456789/66372
Appears in Collections:Vol. 11, № 4

Files in This Item:
File Description SizeFormat 
Voronkov_Semaglutide_25.pdf999 kBAdobe PDFView/Open
Show full item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.